{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:18:52Z","timestamp":1767835132456,"version":"3.49.0"},"reference-count":21,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2019]]},"DOI":"10.7883\/yoken.jjid.2018.374","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T22:29:39Z","timestamp":1545690579000},"page":"149-159","source":"Crossref","is-referenced-by-count":10,"title":["Targets for Optimizing Oral Antibiotic Prescriptions for Pediatric Outpatients in Japan"],"prefix":"10.7883","volume":"72","author":[{"given":"Kazuhiro","family":"Uda","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medical Subspecialties, Research Institute, National Center for Child Health and Development"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medical Subspecialties, Research Institute, National Center for Child Health and Development"},{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"Morisaki","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, Research Institute, National Center for Child Health and Development"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kasai","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Hyogo Prefectural Kobe Children Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuho","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center"},{"name":"Division of Immunology, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyairi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medical Subspecialties, Research Institute, National Center for Child Health and Development"},{"name":"Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Robinson TP, Bu DP, Carrique-Mas J, et al. Antibiotic resistance is the quintessential One Health issue. Trans R Soc Trop Med Hyg. 2016; 110: 377-80.","DOI":"10.1093\/trstmh\/trw048"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3. Giske CG, Monnet DL, Cars O, et al. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008; 52: 813-21.","DOI":"10.1128\/AAC.01169-07"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017; 2: CD003543.","DOI":"10.1002\/14651858.CD003543.pub4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Malani AN, Richards PG, Kapila S, et al. Clinical and economic outcomes from a community hospital&apos;s antimicrobial stewardship program. Am J Infect Control. 2013; 41: 145-8.","DOI":"10.1016\/j.ajic.2012.02.021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Nowak MA, Nelson RE, Breidenbach JL, et al. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health Syst Pharm. 2012; 69: 1500-8.","DOI":"10.2146\/ajhp110603"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Muraki Y, Yagi T, Tsuji Y, et al. Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009\u20132013). J Glob Antimicrob Resist. 2016; 7: 19-23.","DOI":"10.1016\/j.jgar.2016.07.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016; 62:e51-77.","DOI":"10.1093\/cid\/ciw118"},{"key":"8","unstructured":"10. Drekonja D, Filice G, Greer N, et al. Antimicrobial stewardship programs in outpatient settings: a systematic review. Washington (DC): Department of Veterans Affairs; 2014."},{"key":"9","doi-asserted-by":"crossref","unstructured":"15. Gerber JS, Ross RK, Bryan M, et al. Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections. JAMA. 2017; 318: 2325-36.","DOI":"10.1001\/jama.2017.18715"},{"key":"10","doi-asserted-by":"crossref","unstructured":"16. Gerber JS, Prasad PA, Fiks AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA. 2013; 309: 2345-52.","DOI":"10.1001\/jama.2013.6287"},{"key":"11","unstructured":"17. Schuster A, Shwachman H. The tetracyclines; applied pharmacology. In: Grayson ML, Cosgrove SE, Crowe S, et al, editors. Kucers&apos; the Use of Antibiotics: a Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs. 7th ed. Boca Raton, FL: CRC Press; 2017. p1195-1203."},{"key":"12","doi-asserted-by":"crossref","unstructured":"18. Horikoshi Y, Suwa J, Higuchi H, et al. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. Int J Infect Dis. 2017; 64: 69-73.","DOI":"10.1016\/j.ijid.2017.09.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"19. Horikoshi Y, Higuchi H, Suwa J, et al. Impact of computerized pre-authorization of broad spectrum antibiotics in <i>Pseudomonas aeruginosa<\/i> at a children&apos;s hospital in Japan. J Infect Chemother. 2016; 22: 532-5.","DOI":"10.1016\/j.jiac.2016.05.001"},{"key":"14","unstructured":"23. Clinical practice guildeline for the diagnosis and management of acute otitis media (AOM) in children in Japan - 2018. Japan Otological Society. Tokyo: Kanehara Press; 2018. p51-5. Japanese."},{"key":"15","doi-asserted-by":"crossref","unstructured":"24. Hayashi N, Akamatsu H, Iwatsuki K, at al. Japanese dermatological association guidelines: guidelines for the treatment of acne vulgaris 2017. J Dermatol. 2018; 45: 898-935.","DOI":"10.1111\/1346-8138.14355"},{"key":"16","doi-asserted-by":"crossref","unstructured":"25. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017; 65: 1963-73.","DOI":"10.1093\/cid\/cix959"},{"key":"17","unstructured":"26. Ikeda K, Ida O, Kimoto K, et al. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying <i>Escherichia coli<\/i> O157:H7 infection. Clin Nephrol. 1999; 52: 357-62."},{"key":"18","doi-asserted-by":"crossref","unstructured":"27. Tajiri H, Nishi J, Ushijima K, et al. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing <i>Escherichia coli<\/i> infection. Int J Antimicrob Agents. 2015; 46: 586-9.","DOI":"10.1016\/j.ijantimicag.2015.08.006"},{"key":"19","unstructured":"28. Igarashi T. Japanese Society of Pediatric Nephrology. Guidelines for the diagnosis and treatment of hemolytic uremic syndrome. Tokyo:Tokyoigakusya; 2014. p 7-10."},{"key":"20","doi-asserted-by":"crossref","unstructured":"29. Yoshida S, Takeuchi M, Kawakami K. Prescription of antibiotics to pre-school children from 2005 to 2014 in Japan: a retrospective claims database study. J Public Health (Oxf). 2018; 40: 397-403.","DOI":"10.1093\/pubmed\/fdx045"},{"key":"21","doi-asserted-by":"crossref","unstructured":"30. Okubo Y, Michihata N, Morisaki N, et al. Recent patterns in antibiotic use for children with group A streptococcal infections in Japan. J Glob Antimicrob Resist. 2017; 13: 55-9.","DOI":"10.1016\/j.jgar.2017.11.004"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/72\/3\/72_JJID.2018.374\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:39:29Z","timestamp":1558755569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/72\/3\/72_JJID.2018.374\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2018.374","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}